Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to buy: Piramal Pharma, HSCL among 3 top bets by Choice Broking
Stocks to buy: Here's why Aakash Shah, technical analyst at Choice Broking recommends a 'Buy' on Piramal, Aza Engineering and Himadri Speciality Chemical this week.
Five Stocks To Buy: Adani Energy, Adani Green, Gland Pharma And More | June 08, 2026
Top picks include power transmission major Adani Energy Solutions, renewable energy giant Adani Green Energy, pharma player Gland Pharma, automotive major Ashok Leyland, and carbon materials manufacturer Himadri Speciality Chemical.
Manipal Health takes Bengaluru hospital building on long-term lease
Manipal Health Enterprises has leased a 245,000-sq ft multi-speciality hospital in Bengaluru's Yelahanka for nearly 30 years, with an estimated total rental outgo of ₹816.1 crore. The lease agreement includes a starting monthly rent of ₹1.27 crore and a 10% rent escalation in the sixth year.
Gujarat Kidney & Super Speciality consolidated net profit rises 293.75% in the March 2026 quarter
Sales rise 212.68% to Rs 30.58 crore
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.
Park Medi World to acquire Medicity Hospital in Rudrapur, enter Uttarakhand
Hospital chain Park Medi World Limited is acquiring The Medicity Hospital in Rudrapur. The deal is valued at Rs 177 crore and is an all-cash transaction. This acquisition marks Park Group's entry into Uttarakhand. The Medicity Hospital is a multi-super speciality facility with 330 beds. This move aligns with the company's growth strategy to expand its network in underserved markets.
Venus Remedies gets Saudi FDA approval for speciality oncology therapy
Venus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi Food and Drug Authority (SFDA). This hematopoietic stem cell mobilizer is crucial for patients undergoing stem cell transplantation for multiple myeloma and non-Hodgkin lymphoma.
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?
Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady margin outlook despite higher R&D spending, with EBITDA growth supported by diversified global business momentum outlook
Park Medi World Q4 Results: Stock gives up initial spurt despite revenue growth, margin expansion
The group now consolidates 22 subsidiaries, spanning hospital brands including Aggarwal Hospital, Blue Heavens Healthcare, Park Medicity, Kailash Super-Speciality, and Umkal Healthcare, among others.
Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocks
The US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. Sun Pharma faces the steepest risk, while CDMOs like Sai Lifesciences may see selective impact. Analysts at Jefferies and Nomura expect modest to mid-single-digit earnings pressure.
Ambuja Neotia Group to develop over Rs 700 cr integrated healthcare and hospitality project in Guwahati
Ambuja Neotia Group will build a large integrated healthcare and hospitality project in Guwahati. The Rs 700 crore investment will include a 300-bed multi-speciality hospital and a 4+ star hotel. This initiative aims to boost the region's healthcare infrastructure and economy. The project is expected to create thousands of jobs. It marks the group's second healthcare venture in Assam.
Novo Holdings scales up India bets with bigger cheques, focus on mature healthcare assets
The life sciences investor is increasing ticket sizes and doubling down on speciality care and healthcare services as India emerges as a key deployment market in Asia.